| Primary |
| Product Used For Unknown Indication |
29.2% |
| Drug Use For Unknown Indication |
16.7% |
| Gastroenteritis |
12.5% |
| Breast Cancer |
8.3% |
| Hypertension |
8.3% |
| Vomiting |
8.3% |
| Chemotherapy |
4.2% |
| Chest Pain |
4.2% |
| Gastritis Prophylaxis |
4.2% |
| Premedication |
4.2% |
|
| Vomiting |
18.8% |
| Laryngeal Oedema |
12.5% |
| Melaena |
12.5% |
| Overdose |
12.5% |
| Drug Administration Error |
6.3% |
| Erythema |
6.3% |
| Hypertransaminasaemia |
6.3% |
| Pruritus Generalised |
6.3% |
| Rash Erythematous |
6.3% |
| Thrombosis |
6.3% |
| Urticaria |
6.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.3% |
| Premedication |
32.3% |
| Breast Cancer |
16.1% |
| Haematotoxicity |
9.7% |
| Chemotherapy |
3.2% |
| Prophylaxis |
3.2% |
| Vomiting |
3.2% |
|
| Visual Field Defect |
25.0% |
| Hepatic Steatosis |
12.5% |
| Hypotension |
12.5% |
| Oral Fungal Infection |
12.5% |
| Rash |
12.5% |
| Thrombocytopenia |
12.5% |
| Vomiting |
12.5% |
|
| Concomitant |
| Colon Cancer |
14.9% |
| Product Used For Unknown Indication |
13.8% |
| Breast Cancer |
9.0% |
| Prophylaxis Of Nausea And Vomiting |
8.3% |
| Prophylaxis |
7.2% |
| Premedication |
5.7% |
| Adenocarcinoma Of Colon |
4.9% |
| Lung Neoplasm Malignant |
4.6% |
| Ascites |
4.2% |
| Non-hodgkin's Lymphoma |
3.5% |
| Non-small Cell Lung Cancer |
3.3% |
| Rectal Cancer |
3.2% |
| Hypertension |
2.8% |
| Lung Adenocarcinoma |
2.8% |
| Acute Lymphocytic Leukaemia |
2.4% |
| B-cell Lymphoma |
2.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Ovarian Cancer |
1.8% |
| Anaphylaxis Prophylaxis |
1.7% |
| Dehydration |
1.7% |
|
| Vomiting |
39.2% |
| Stomatitis |
9.2% |
| Pain In Extremity |
4.6% |
| Loss Of Consciousness |
3.8% |
| Rash |
3.8% |
| Fatigue |
3.1% |
| Feeling Hot |
3.1% |
| Hyperamylasaemia |
3.1% |
| Pyrexia |
3.1% |
| Renal Failure |
3.1% |
| Retching |
3.1% |
| Cardio-respiratory Arrest |
2.3% |
| Dyspnoea |
2.3% |
| Formication |
2.3% |
| Hyponatraemia |
2.3% |
| Hypotension |
2.3% |
| Infusion Related Reaction |
2.3% |
| Off Label Use |
2.3% |
| Paraesthesia |
2.3% |
| Pneumonia |
2.3% |
|
